| NCT ID | NCT03866382 |
| Title | Cabozantinib in Combination With Nivolumab and Ipilimumab in Rare Genitourinary Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | National Cancer Institute (NCI) |
| Indications |
papillary renal cell carcinoma sarcomatoid transitional cell carcinoma urinary bladder small cell neuroendocrine carcinoma bladder squamous cell carcinoma |
| Therapies | |
| Age Groups: | senior adult |